WA
Wheatland Advisors Portfolio holdings
AUM
$24.1M
This Quarter Return
+3.16%
1 Year Return
+5.34%
3 Year Return
+30.52%
5 Year Return
+57.58%
10 Year Return
–
AUM
$110M
AUM Growth
+$110M
(-17%)
Cap. Flow
-$25.5M
Cap. Flow
% of AUM
-23.2%
Top 10 Holdings %
Top 10 Hldgs %
33.02%
Holding
99
New
1
Increased
2
Reduced
69
Closed
1
Top Buys
| 1 |
Hershey
HSY
|
$204K |
| 2 |
AbbVie
ABBV
|
$530 |
| 3 |
Essential Utilities
WTRG
|
$90 |
Top Sells
| 1 |
L3Harris
LHX
|
$1.64M |
| 2 |
Eli Lilly
LLY
|
$1.32M |
| 3 |
Truist Financial
TFC
|
$1.22M |
| 4 |
Intel
INTC
|
$1.19M |
| 5 |
Marathon Petroleum
MPC
|
$1.14M |
Sector Composition
| 1 | Healthcare | 20.32% |
| 2 | Technology | 14.13% |
| 3 | Financials | 13.15% |
| 4 | Industrials | 10.82% |
| 5 | Energy | 10.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
RTX Corp
RTX
$212B
| $1.46M | 1.32% |
10,675
-3,425
| -24% | -$467K |
|
27
Stryker
SYK
$150B
| $1.41M | 1.28% |
6,514
-200
| -3% | -$43.3K |
|
28
Tompkins Financial
TMP
$1.01B
| $1.4M | 1.27% |
17,218
-10,874
| -39% | -$882K |
|
29
Kellanova
K
$27.6B
| $1.4M | 1.27% |
21,671
-6,510
| -23% | -$419K |
|
30
Walmart
WMT
$774B
| $1.34M | 1.22% |
11,302
-120
| -1% | -$14.2K |
|
31
Thermo Fisher Scientific
TMO
$186B
| $1.31M | 1.19% |
4,500
| – | – |
|
32
Berkshire Hathaway Class A
BRK.A
$1.09T
| $1.25M | 1.13% |
400
| – | – |
|
33
Sysco
SYY
$38.5B
| $1.23M | 1.12% |
15,507
-300
| -2% | -$23.8K |
|
|
UN
34
DELISTED
Unilever NV New York Registry Shares
UN
| $1.2M | 1.09% |
19,963
-3,700
| -16% | -$222K |
|
|
WBA
35
DELISTED
Walgreens Boots Alliance
WBA
| $1.19M | 1.08% |
21,574
-3,345
| -13% | -$185K |
|
36
Martin Marietta Materials
MLM
$37.2B
| $1.14M | 1.04% |
4,175
-900
| -18% | -$247K |
|
37
Johnson Controls International
JCI
$69.9B
| $1.08M | 0.98% |
24,607
-934
| -4% | -$41K |
|
38
PNC Financial Services
PNC
$81.7B
| $1.07M | 0.97% |
7,644
-1,387
| -15% | -$194K |
|
39
Mastercard
MA
$538B
| $1.07M | 0.97% |
3,925
-100
| -2% | -$27.2K |
|
40
Novartis
NVS
$245B
| $1.01M | 0.92% |
11,625
-2,050
| -15% | -$178K |
|
41
Qualcomm
QCOM
$173B
| $986K | 0.9% |
12,930
-6,480
| -33% | -$494K |
|
42
Coca-Cola
KO
$297B
| $945K | 0.86% |
17,350
-6,000
| -26% | -$327K |
|
43
Chevron
CVX
$324B
| $892K | 0.81% |
7,522
| – | – |
|
44
Bristol-Myers Squibb
BMY
$96B
| $882K | 0.8% |
17,400
-11,000
| -39% | -$558K |
|
45
Wells Fargo
WFC
$263B
| $872K | 0.79% |
17,292
-2,600
| -13% | -$131K |
|
46
Pfizer
PFE
$141B
| $846K | 0.77% |
23,552
-19,296
| -45% | -$693K |
|
47
WPP
WPP
$5.73B
| $844K | 0.77% |
13,479
-3,375
| -20% | -$211K |
|
48
IBM
IBM
$227B
| $806K | 0.73% |
5,540
-50
| -0.9% | -$7.27K |
|
49
West Pharmaceutical
WST
$17.8B
| $794K | 0.72% |
5,600
| – | – |
|
50
Merck
MRK
$210B
| $764K | 0.69% |
9,072
-1,152
| -11% | -$97K |
|